Displaying 21 to 38 of 38 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Lycera Corp |
United States | 1 Apr 2009 | Series A |
|
|
NanoString Technologies Inc A life sciences company, markets solutions for detecting and counting large sets of target molecules in biological samples for researchers. |
United States | 1 Jun 2009 | Series C Active |
|
|
|
NanoString Technologies Inc A life sciences company, markets solutions for detecting and counting large sets of target molecules in biological samples for researchers. |
United States | 1 Nov 2011 | Series D Active |
|
|
|
Oxford Immunotec Ltd |
United Kingdom | 29 Oct 2007 | Series C Led the investment round. Active |
|
|
|
Oxford Immunotec Ltd |
United Kingdom | 1 Apr 2010 | Series D Active |
|
|
|
Oxford Immunotec Ltd |
United Kingdom | 18 Jun 2012 | Venture Round participant. Active |
|
|
|
Pearl Therapeutics Inc Developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases |
United States | 1 Feb 2010 | N/A |
|
|
|
Pearl Therapeutics Inc Developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases |
United States | 1 Sep 2007 | N/A |
|
|
|
Proacta Inc |
United States | 1 Feb 2007 | Series B |
|
|
|
SARcode Bioscience Inc |
United States | 1 Jul 2011 | Series B |
|
|
|
Sientra Inc Medical device company |
United States | Series C |
||
|
|
Taligen Therapeutics Inc |
United States | N/A |
||
|
|
TyRx Inc |
United States | 1 Feb 2008 | N/A |
|
|
|
TyRx Inc |
United States | 1 Dec 2010 | N/A |
|
|
|
VBI Vaccines Inc A biotechnology company, engages in the formulation, development, and delivery of vaccines in the United States and internationally. |
United States | N/A |
||
|
|
Virdante Pharmaceuticals Inc A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. |
United States | 31 Dec 2008 | Series A |
|
|
Zogenix Inc A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. |
United States | 1 Jan 2008 | N/A Initial investment. Round participant. Active |
|
|
|
Zogenix Inc A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. |
United States | 1 Sep 2009 | Series B Follow-on investment. Round participant. Active |